Seahorse Bio, Moffitt Cancer Center Nab SBIR Contract to Measure 3D Tissue Metabolism


Exiqon Posts 17 Percent Revenue Growth for Q3


BioFire Defense Receives Emergency Use Authorization for Two FilmArray Ebola Tests


NCCN Mentions Prolaris, Oncotype DX in Updated Prostate Cancer Guidelines


Exact Sciences Reports No Revenues for Q3 as Firm Begins Commercialization of Cologuard Test


Most Viewed Articles on GWDN Last Week


NCCN Including Use of VeriStrat in NSCLC Guidelines


Amoy Diagnostics Obtains CE Mark for Cancer Mutation Assays


Seven Bridges Gets NCI Cloud Pilot Contract, Tailoring its Own AWS-based System for Cancer Research


BioDiscovery Enters New Market with Launch of Tailored Software for Clinical CNV